Hodgkin's disease

(redirected from Hodgkin's lymphoma)
Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

Hodg·kin's disease

 (hŏj′kĭnz)
n.
A malignant, progressive, sometimes fatal disease of unknown cause, marked by enlargement of the lymph nodes, spleen, and liver. Also called Hodgkin's lymphoma.

[After Thomas Hodgkin, (1798-1866), British physician.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

Hodgkin's disease

(ˈhɒdʒkɪnz)
n
(Pathology) a malignant disease, a form of lymphoma, characterized by painless enlargement of the lymph nodes, spleen, and liver. Also called: lymphoadenoma or lymphogranulomatosis
[C19: named after Thomas Hodgkin (1798–1866), London physician, who first described it]
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

Hodg′kin's disease`


n.
a malignant disorder characterized by enlargement of the lymph nodes and spleen and by lymphoid infiltration along the blood vessels.
[1860–65; after Thomas Hodgkin (1798–1866), London physician who described it]
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.

Hodgkin's disease

A disorder of the lymphatic system in which the lymphoid tissue multiplies rapidly. This can damage the immune system and can result in infections, which are normally considered minor, becoming fatal.
Dictionary of Unfamiliar Words by Diagram Group Copyright © 2008 by Diagram Visual Information Limited
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.Hodgkin's disease - a malignant disorder in which there is progressive (but painless) enlargement of lymph tissue followed by enlargement of the spleen and liver
lymphoma - a neoplasm of lymph tissue that is usually malignant; one of the four major types of cancer
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations

Hodgkin's disease

n. enfermedad de Hodgkin, presencia de tumores malignos en los nódulos linfáticos y el bazo.
English-Spanish Medical Dictionary © Farlex 2012
References in periodicals archive ?
Diffuse large cell lymphomas: identification of prognostic factors and validation of the International Non Hodgkin's Lymphoma Prognostic Index.
A lymphoma which demonstrates transitional morphologic and immunophenotypic features between classical Hodgkin's lymphoma (CHL) and large B-cell lymphoma (diffuse large B cell lymphoma and Burkitt's lymphoma), mostly presenting with a mediastinal but occasionally with a peripheral lymph node disease is termed as grey zone lymphoma (GZL) as shown in figure 2.1,2 The terms "gray zone or grey zone or unclassifiable or indeterminate or mediastinal grey zone lymphoma (MGZL)" are synonymous and are used interchangeably.3,4 The outcome of these cases may differ from DLBCL and CHL.5 These lymphomas may show three types of features:
M2 EQUITYBITES-August 31, 2018-Chinese regulator accepts BeiGene's NDA for Hodgkin's lymphoma treatment
Langerhans Cell Histiocytosis Followed by Hodgkin's Lymphoma. Korean J Intern Med.
Key Words: Non Hodgkin's Lymphoma, CD20, B cell Lymphoma
But after being diagnosed with Hodgkin's Lymphoma she spent the first weeks of her baby's life writing heartfelt letters to her daughter in fear that she may never see her grow up.
Tranformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin's lymphoma. J Clin Oncol.
DENVER -- Long-term survivors of Hodgkin's lymphoma are at increased risk for pneumonia and other severe infections, even 20 years or more after the diagnosis of their malignancy, according to a Swedish national study.
Involved-nodal radiation therapy as a component therapy for limited-stage Hodgkin's lymphoma: A question of field size.
HODGKIN'S Disease and non- Hodgkin's lymphoma are the most common types of lymph gland cancer.
The drug has already been approved in Europe as a treatment for CD30-positive Hodgkin's lymphoma patients with: relapsed or refractory Hodgkin's lymphoma after autologous stem cell transplant; a high risk of disease relapse or progression; and relapsed or refractory disease after two previous treatments when autologous stem cell transplant or multi-agent chemotherapy is not suitable.
The epidemiology of Non- Hodgkin's lymphoma: comparison of nodal and extra-nodal sites.